Merit Medical Systems Inc (MMSI)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 162,165 162,045 159,847 142,483 127,600 123,470 107,840 101,307 88,969 77,941 73,918 60,120 59,178 53,075 37,678 9,842 -3,237 -23,264 -25,552 6,147
Long-term debt US$ in thousands 729,551 750,505 801,321 800,136 823,013 282,370 335,232 186,423 186,759 205,412 235,703 243,112 234,397 271,181 284,900 312,875 343,722 349,813 402,915 438,137
Total stockholders’ equity US$ in thousands 1,379,360 1,323,410 1,282,440 1,240,190 1,202,000 1,229,880 1,203,700 1,171,660 1,144,400 1,088,840 1,073,310 1,056,520 1,039,800 1,013,380 992,434 976,692 958,575 933,837 928,847 939,798
Return on total capital 7.69% 7.81% 7.67% 6.98% 6.30% 8.16% 7.01% 7.46% 6.68% 6.02% 5.65% 4.63% 4.64% 4.13% 2.95% 0.76% -0.25% -1.81% -1.92% 0.45%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $162,165K ÷ ($729,551K + $1,379,360K)
= 7.69%

The return on total capital for Merit Medical Systems Inc has exhibited fluctuation over the period from March 31, 2020, to December 31, 2024. The ratio started at a modest 0.45% in March 2020, dipped into negative territory in the following quarters, and then steadily improved reaching 7.81% by September 30, 2024. This improvement indicates the company's ability to generate higher returns relative to the total capital employed in its operations. Despite some variability, the return on total capital generally experienced an upward trend, with some minor fluctuations along the way. This suggests that the company has been effectively utilizing its capital to generate returns for its stakeholders. It is important for the company to sustain and potentially enhance this performance to continue creating value for investors.